Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'BACTERICIDAL ANTIBODIES' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 63 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Prince, SM; Feron, C; Janssens, D; Lobet, Y; Achtman, M; Kusecek, B; Bullough, PA; Derrick, JP
      Expression, refolding and crystallization of the OpcA invasin from Neisseria meningitidis

      ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
    2. Carmenate, T; Mesa, C; Menendez, T; Falcon, V; Musacchio, A
      Recombinant Opc protein from Neisseria meningitidis reconstituted into liposomes elicits opsonic antibodies following immunization

      BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
    3. Sacchi, CT; Lemos, APS; Popovic, T; de Morais, JC; Whitney, AM; Melles, CEA; Brondi, LMG; Monteiro, LMC; Paiva, MV; Solari, CA; Mayer, LW
      Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolatedin Brazil during 1997-1998: Overview and implications for vaccine development

      JOURNAL OF CLINICAL MICROBIOLOGY
    4. de Kleijn, ED; de Groot, R; Lafeber, AB; Labadie, J; van Limpt, CJP; Visser, J; Berbers, GAM; van Alphen, L; Rumke, HC
      Prevention of meningococcal serogroup B infections in children: A protein-based vaccine induces immunologic memory

      JOURNAL OF INFECTIOUS DISEASES
    5. Coppens, I; Alonso, S; Antoine, R; Jacob-Dubuisson, F; Renauld-Mongenie, G; Jacobs, E; Locht, C
      Production of Neisseria meningitidis transferrin-binding protein B by recombinant Bordetella pertussis

      INFECTION AND IMMUNITY
    6. McMichael, JC
      Progress toward the development of a vaccine to prevent Moraxella (Branhamella) catarrhalis infections

      MICROBES AND INFECTION
    7. Jansen, C; Kuipers, B; van der Biezen, J; de Cock, H; van der Ley, P; Tommassen, J
      Immunogenicity of in vitro folded outer membrane protein PorA of Neisseriameningitidis

      FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
    8. Pollard, AJ; Levin, M
      Vaccines for prevention of meningococcal disease

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    9. McMichael, JC
      Vaccines for Moraxella catarrhalis

      VACCINE
    10. Rios, IE; Garcia-Fulgueiras, A; Alonso, JAN; Moreno, JV; Gonzalez, TR; Sanchez, CN; Perez-Flores, D
      Seroconversion and duration of immunity after vaccination against group C meningococcal infection in young children

      VACCINE
    11. Martin, SL; Borrow, R; van der Ley, P; Dawson, M; Fox, AJ; Cartwright, KAV
      Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine

      VACCINE
    12. de Kleijn, ED; de Groot, R; Labadie, J; Lafeber, AB; van den Dobbelsteen, G; van Alphen, L; van Dijken, H; Kuipers, B; van Omme, GW; Wala, M; Juttmann, R; Rumke, HC
      Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age

      VACCINE
    13. van der Voort, ER; Schuller, M; Holst, J; de Vries, P; van der Ley, P; van den Dobbelsteen, G; Poolman, J
      Immunogenicity studies with a genetically engineered hexavalent PorA and awild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys

      VACCINE
    14. Koroev, DO; Kotelnikova, OV; Volpina, OM; Zhmak, MN; Kupriyanova, MA; Agafonova, SA; Alliluev, AP; Litvinov, IS; Nesmeyanov, VA; Ivanov, VT
      Induction of antimeningitis immunity by the synthetic peptides. I. The immunoactive synthetic fragments of porin A from Neisseria meningitidis

      BIOORGANICHESKAYA KHIMIYA
    15. Tondella, MLC; Popovic, T; Rosenstein, NE; Lake, DB; Carlone, GM; Mayer, LW; Perkins, BA
      Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States

      JOURNAL OF CLINICAL MICROBIOLOGY
    16. Schulz-Utermoehl, T; Edwards, RJ; Boobis, AR
      Affinity and potency of proinhibitory antipeptide antibodies against CYP2D6 is enhanced using cyclic peptides as immunogens

      DRUG METABOLISM AND DISPOSITION
    17. Sacchi, CT; Whitney, AM; Popovic, T; Beall, DS; Reeves, MW; Plikaytis, BD; Rosenstein, NE; Perkins, BA; Tondella, MLC; Mayer, LW
      Diversity and prevalence of PorA types in Neisseria meningitidis serogroupB in the United States, 1992-1998

      JOURNAL OF INFECTIOUS DISEASES
    18. Rokbi, B; Renauld-Mongenie, G; Mignon, M; Danve, B; Poncet, D; Chabanel, C; Caugant, DA; Quentin-Millet, MJ
      Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: Implication for the composition of a recombinant TbpB-basedvaccine

      INFECTION AND IMMUNITY
    19. Wang, JF; Jarvis, GA; Achtman, M; Rosenqvist, E; Michaelsen, TE; Aase, A; Griffiss, JM
      Functional activities and immunoglobulin variable regions of human and murine monoclonal antibodies specific for the P1.7 PorA protein loop of Neisseria meningitidis

      INFECTION AND IMMUNITY
    20. Sardinas, G; Gonzalez, S; Garay, HE; Nazabal, C; Reyes, O; Silva, R
      Anti-PorA antibodies elicited by immunization with peptides conjugated to P64k

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    21. Patel, G; Husman, W; Jehanli, AM; Deadman, JJ; Green, D; Kakkar, VV; Brennand, DM
      A cyclic peptide analogue of the loop III region of platelet-derived growth factor-BB is a synthetic antigen for the native protein

      JOURNAL OF PEPTIDE RESEARCH
    22. Moe, GR; Tan, SQ; Granoff, DM
      Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease

      FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
    23. Oftung, F; Lovik, M; Andersen, SR; Froholm, LO; Bjune, G
      A mouse model utilising human transferrin to study protection against Neisseria meningitidis serogroup B induced by outer membrane vesicle vaccination

      FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
    24. Mathers, K; Leinonen, M; Goldblatt, D
      Antibody response to outer membrane proteins of Moraxella catarrhalis in children with otitis media

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    25. Potter, AA; Schryvers, AB; Ogunnariwo, JA; Hutchins, WA; Lo, RYC; Watts, T
      Protective capacity of the Pasteurella haemolytica transferrin-binding proteins TbpA and TbpB in cattle

      MICROBIAL PATHOGENESIS
    26. Chen, DX; McMichael, JC; VanDerMeid, KR; Masi, AW; Bortell, E; Caplan, JD; Chakravarti, DN; Barniak, VL
      Evaluation of a 74-kDa transferrin-binding protein from Moraxella (Branhamella) catarrhalis as a vaccine candidate

      VACCINE
    27. Christodoulides, M; Rattue, E; Heckels, JE
      Effect of adjuvant composition on immune response to a multiple antigen peptide (MAP) containing a protective epitope from Neisseria meningitidis class 1 porin

      VACCINE
    28. Brieske, N; Schenker, M; Schnibbe, T; Quentin-Millet, MJ; Achtman, M
      Human antibody responses to A and C capsular polysaccharides, IgA1 protease and transferrin-binding protein complex stimulated by infection with Neisseria meningitidis of subgroup IV-1 or ET-37 complex

      VACCINE
    29. Peeters, CCAM; Claassen, IJTM; Schuller, M; Kersten, GFA; van der Voort, EMR; Poolman, JT
      Immunogenicity of various presentation forms of PorA outer membrane protein of Neisseria meningitidis in mice

      VACCINE
    30. Tappero, JW; Lagos, R; Ballesteros, AM; Plikaytis, B; Williams, D; Dykes, J; Gheesling, LL; Carlone, GM; Hoiby, EA; Holst, J; Nokleby, H; Rosenqvist, E; Sierra, G; Campa, C; Sotolongo, F; Vega, J; Garcia, J; Herrera, P; Poolman, JT; Perkins, BA
      Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines - A randomized controlled trial in Chile

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    31. Murphy, TF; Kirkham, C; DeNardin, E; Sethi, S
      Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis

      INFECTION AND IMMUNITY
    32. Yu, RH; Bonnah, RA; Ainsworth, S; Schryvers, AB
      Analysis of the immunological responses to transferrin and lactoferrin receptor proteins from Moraxella catarrhalis

      INFECTION AND IMMUNITY
    33. Rosenqvist, E; Musacchio, A; Aase, A; Hoiby, EA; Namork, E; Kolberg, J; Wedege, E; Delvig, A; Dalseg, R; Michaelsen, TE; Tommassen, J
      Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis

      INFECTION AND IMMUNITY
    34. Luke, NR; Russo, TA; Luther, N; Campagnari, AA
      Use of an isogenic mutant constructed in Moraxella catarrhalis to identifya protective epitope of outer membrane protein B1 defined by monoclonal antibody 11C6

      INFECTION AND IMMUNITY
    35. Lehmann, AK; Gorringe, AR; Reddin, KM; West, K; Smith, I; Halstensen, A
      Human opsonins induced during meningococcal disease recognize transferrin binding protein complexes

      INFECTION AND IMMUNITY
    36. Moe, GR; Tan, SQ; Granoff, DM
      Differences in surface expression of NspA among Neisseria meningitidis group B strains

      INFECTION AND IMMUNITY
    37. Luke, NR; Campagnari, AA
      Construction and characterization of Moraxella catarrhalis mutants defective in expression of transferrin receptors

      INFECTION AND IMMUNITY
    38. Steeghs, L; Kuipers, B; Hamstra, HJ; Kersten, G; van Alphen, L; van der Ley, P
      Immunogenicity of outer membrane proteins in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: Influence of adjuvants on the immune response

      INFECTION AND IMMUNITY
    39. Menendez, T; Perez, M; Alvarez, A
      Antigenic and genetic characterization of a putative hybrid transferrin-binding protein B from Neisseria meningitidis

      CANADIAN JOURNAL OF MICROBIOLOGY
    40. FERREIROS CM; GOMEZ JA; CRIADO MT
      PREVENTION OF MENINGOCOCCAL DISEASE - PRESENT AND FUTURE

      Reviews in medical micro-biology
    41. VANHOECKE C; FU D; DEGRAVE D; VOET P; LEBACQ E
      CLINICAL AND IMMUNOLOGICAL ASSESSMENT OF A CANDIDATE LYME-DISEASE VACCINE IN HEALTHY-ADULTS - ANTIBODY PERSISTENCE AND EFFECT OF A BOOSTER DOSE AT MONTH 12

      Vaccine
    42. Kraiczy, P; Peters, S; Seitz, C; Wurzner, R; Oschmann, P; Brade, V
      Growth inhibitory and bactericidal efficacy of sera from Lyme borreliosis patients on B-burgdorferi strains

      WIENER KLINISCHE WOCHENSCHRIFT
    43. PINTOR M; GOMEZ JA; FERRON L; FERREIROS CM; CRIADO MT
      ANALYSIS OF TBPA AND TBPB FUNCTIONALITY IN DEFECTIVE-MUTANTS OF NEISSERIA-MENINGITIDIS

      Journal of Medical Microbiology
    44. WEDEGE E; HOIBY EA; ROSENQVIST E; BJUNE G
      IMMUNE-RESPONSES AGAINST MAJOR OUTER-MEMBRANE ANTIGENS OF NEISSERIA-MENINGITIDIS IN VACCINEES AND CONTROLS WHO CONTRACTED MENINGOCOCCAL DISEASE DURING THE NORWEGIAN SEROGROUP-B PROTECTION TRIAL

      Infection and immunity
    45. ROKBI B; MIGNON M; CAUGANT DA; QUENTINMILLET MJ
      HETEROGENEITY OF TBPB, THE TRANSFERRIN-BINDING PROTEIN-B GENE, AMONG SEROGROUP-B NEISSERIA-MENINGITIDIS STRAINS OF THE ET-5 COMPLEX

      Clinical and diagnostic laboratory immunology
    46. MUSACCHIO A; CARMENATE T; DELGADO M; GONZALEZ S
      RECOMBINANT OPC MENINGOCOCCAL PROTEIN, FOLDED IN-VITRO, ELICITS BACTERICIDAL ANTIBODIES AFTER IMMUNIZATION

      Vaccine
    47. BRANDT ER; HAYMAN WA; CURRIE B; PRUKSAKORN S; GOOD MF
      HUMAN-ANTIBODIES TO THE CONSERVED REGION OF THE M-PROTEIN - OPSONIZATION OF HETEROLOGOUS STRAINS OF GROUP-A STREPTOCOCCI

      Vaccine
    48. MARTIN D; CADIEUX N; HAMEL J; BRODEUR BR
      HIGHLY CONSERVED NEISSERIA-MENINGITIDIS SURFACE PROTEIN CONFERS PROTECTION AGAINST EXPERIMENTAL-INFECTION

      The Journal of experimental medicine
    49. RENAULDMONGENIE G; PONCET D; VONOLLESCHIKELBHEIM L; COURNEZ T; MIGNON M; SCHMIDT MA; QUENTINMILLET MJ
      IDENTIFICATION OF HUMAN TRANSFERRIN-BINDING SITES WITHIN MENINGOCOCCAL TRANSFERRIN-BINDING PROTEIN-B

      Journal of bacteriology
    50. VANDERVOORT ER; VANDIJKEN H; KUIPERS B; VANDERBIEZEN J; VANDERLEY P; MEYLIS J; CLAASSEN I; POOLMAN J
      HUMAN B-CELL AND T-CELL RESPONSES AFTER IMMUNIZATION WITH A HEXAVALENT PORA MENINGOCOCCAL OUTER-MEMBRANE VESICLE VACCINE

      Infection and immunity
    51. CLAASSEN I; MEYLIS J; VANDERLEY P; PEETERS C; BRONS H; ROBERT J; BORSBOOM D; VANDERARK A; VANSTRAATEN I; ROHOLL P; KUIPERS B; POOLMAN J
      PRODUCTION, CHARACTERIZATION AND CONTROL OF A NEISSERIA-MENINGITIDIS HEXAVALENT CLASS-1 OUTER-MEMBRANE PROTEIN CONTAINING VESICLE VACCINE

      Vaccine
    52. PINTOR M; FERRON L; GOMEZ JA; GORRINGE A; CRIADO MT; FERREIROS CM
      BLOCKING OF IRON UPTAKE BY MONOCLONAL-ANTIBODIES SPECIFIC FOR THE NEISSERIA-MENINGITIDIS TRANSFERRIN-BINDING PROTEIN-2

      Journal of Medical Microbiology
    53. DELVIG AA; WEDEGE E; CAUGANT DA; DALSEG R; KOLBERG J; ACHTMAN M; ROSENQVIST E
      A LINEAR B-CELL EPITOPE AN THE CLASS-3 OUTER-MEMBRANE PROTEIN OF NEISSERIA-MENINGITIDIS RECOGNIZED AFTER VACCINATION WITH THE NORWEGIAN GROUP-B OUTER-MEMBRANE VESICLE VACCINE

      Microbiology
    54. DELAPAZ H; COOKE SJ; HECKELS JE
      EFFECT OF SIALYLATION OF LIPOPOLYSACCHARIDE OF NEISSERIA-GONORRHOEAE ON RECOGNITION AND COMPLEMENT-MEDIATED KILLING BY MONOCLONAL-ANTIBODIES DIRECTED AGAINST DIFFERENT OUTER-MEMBRANE ANTIGENS

      Microbiology
    55. GRANOFF DM; KELSEY SK; BIJLMER HA; VANALPHEN L; DANKERT J; MANDRELL RE; AZMI FH; SCHOLTEN RJPM
      ANTIBODY-RESPONSES TO THE CAPSULAR POLYSACCHARIDE OF NEISSERIA-MENINGITIDIS SEROGROUP-B IN PATIENTS WITH MENINGOCOCCAL DISEASE

      Clinical and diagnostic laboratory immunology
    56. WEDEGE E; KOLBERG J; DELVIG A; HOIBY EA; HOLTEN E; ROSENQVIST E; CAUGANT DA
      EMERGENCE OF A NEW VIRULENT CLONE WITHIN THE ELECTROPHORETIC TYPE 5 COMPLEX OF SEROGROUP-B MENINGOCOCCI IN NORWAY

      Clinical and diagnostic laboratory immunology
    57. POOLMAN JT
      DEVELOPMENT OF A MENINGOCOCCAL VACCINE

      Infectious agents and disease
    58. WALLACE FJ; WITT CS; CLANCY RL; CRIPPS AW
      PROTECTION AGAINST NONTYPABLE HAEMOPHILUS-INFLUENZAE FOLLOWING SENSITIZATION OF GUT-ASSOCIATED LYMPHOID-TISSUE - ROLE OF SPECIFIC ANTIBODY AND PHAGOCYTES

      Immunology and cell biology
    59. VANDERLEY P; VANDERBIEZEN J; POOLMAN JT
      CONSTRUCTION OF NEISSERIA-MENINGITIDIS STRAINS CARRYING MULTIPLE CHROMOSOMAL COPIES OF THE POR-A GENE FOR USE IN THE PRODUCTION OF A MULTIVALENT OUTER-MEMBRANE VESICLE VACCINE

      Vaccine
    60. IDANPAANHEIKKILA I; HOIBY EA; CHATTOPADHYAY P; AIRAKSINEN U; MICHAELSEN TM; WEDEGE E
      ANTIBODIES TO MENINGOCOCCAL CLASS-1 OUTER-MEMBRANE PROTEIN AND ITS VARIABLE REGIONS IN PATIENTS WITH SYSTEMIC MENINGOCOCCAL DISEASE

      Journal of Medical Microbiology
    61. ROSENQVIST E; HOIBY EA; WEDEGE E; BRYN K; KOLBERG J; KLEM A; RONNILD E; BJUNE G; NOKLEBY H
      HUMAN-ANTIBODY RESPONSES TO MENINGOCOCCAL OUTER-MEMBRANE ANTIGENS AFTER 3 DOSES OF THE NORWEGIAN GROUP-B MENINGOCOCCAL VACCINE

      Infection and immunity
    62. DELVIG A; JAHN S; KUSECEK B; HECKELS JE; ROSENQVIST E; HOIBY EA; MICHAELSEN TE; ACHTMAN M
      A COMPARISON OF HUMAN AND MURINE MONOCLONAL IGGS SPECIFIC FOR THE P1.7 PORA PROTEIN OF NEISSERIA-MENINGITIDIS

      Molecular immunology
    63. ROSENQVIST E; HOIBY EA; WEDEGE E; CAUGANT DA; FROHOLM LO; MCGUINNESS BT; BROOKS J; LAMBDEN PR; HECKELS JE
      A NEW VARIANT OF SEROSUBTYPE P1.16 IN NEISSERIA-MENINGITIDIS FROM NORWAY, ASSOCIATED WITH INCREASED RESISTANCE TO BACTERICIDAL ANTIBODIES INDUCED BY A SEROGROUP-B OUTER-MEMBRANE PROTEIN VACCINE

      Microbial pathogenesis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/01/21 alle ore 14:39:49